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Measuring freezing of gait during daily‑life:
an open‑source, wearable sensors approach
Martina Mancini1* , Vrutangkumar V. Shah1, Samuel Stuart1,2, Carolin Curtze3, Fay B. Horak1,
Delaram Safarpour1 and John G. Nutt1

Abstract
Background: Although a growing number of studies focus on the measurement and detection of freezing of gait
(FoG) in laboratory settings, only a few studies have attempted to measure FoG during daily life with body-worn
sensors. Here, we presented a novel algorithm to detect FoG in a group of people with Parkinson’s disease (PD) in the
laboratory (Study I) and extended the algorithm in a second cohort of people with PD at home during daily life (Study
II).
Methods: In Study I, we described of our novel FoG detection algorithm based on five inertial sensors attached to
the feet, shins and lumbar region while walking in 40 participants with PD. We compared the performance of the
algorithm with two expert clinical raters who scored the number of FoG episodes from video recordings of walking
and turning based on duration of the episodes: very short (< 1 s), short (2–5 s), and long (> 5 s). In Study II, a different cohort of 48 people with PD (with and without FoG) wore 3 wearable sensors on their feet and lumbar region for
7 days. Our primary outcome measures for freezing were the % time spent freezing and its variability.
Results: We showed moderate to good agreement in the number of FoG episodes detected in the laboratory (Study
I) between clinical raters and the algorithm (if wearable sensors were placed on the feet) for short and long FoG
episodes, but not for very short FoG episodes. When extending this methodology to unsupervised home monitoring
(Study II), we found that percent time spent freezing and the variability of time spent freezing differentiated between
people with and without FoG (p < 0.05), and that short FoG episodes account for 69% of the total FoG episodes.
Conclusion: Our findings showed that objective measures of freezing in PD using inertial sensors on the feet in the
laboratory are matching well with clinical scores. Although results found during daily life are promising, they need
to be validated. Objective measures of FoG with wearable technology during community-living would be useful for
managing this distressing feature of mobility disability in PD.
Keywords: Wearable sensors, Freezing of gait, Parkinson’s disease, Freezing of Gait Questionnaire, Home monitoring
Background
Gait disturbances, such as reduced gait speed, shorter
stride length, increased time of double support and
slow turns, occur early in Parkinson’s disease (PD) and
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progress over time [1, 2]. It is also estimated that over
80% of people with PD eventually develop freezing of gait
(FoG), an intermittent failure to initiate or maintain locomotion [3, 4]. FoG and slow walking are the most significant factors affecting the quality of life in people with PD
and are associated with an increased risk of falls [5]. FoG
episodes can be very short (< 1 s), short (2–5 s) or long
(> 5 s) and are more common during walking conditions
typical of daily life than during straight walking in a clinic
or laboratory (i.e.; turning, gait initiation, when walking
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through doorways or when performing a concurrent
dual-task when walking [6, 7]).
Objectively assessing the severity of FoG is challenging from both a clinical and a research perspective [7,
8]. In fact, as recently summarized in our previous work
[8], there still isn’t an optimal freezing score that clinicians can use. The ‘gold-standard’ to assess the presence of freezing (from actual video recordings [9, 10] or
computer-generated animations [11]) is time consuming
and does not represent daily fluctuations. Assessment
of FoG in the clinic or laboratory is challenged by the
fact that these assessment do not accurately represent
severity or extent of FoG in daily life [12, 13]. Increased
attention, alertness, and effort to impress the examiner
during testing may improve gait performance [14–16].
This is particularly true for FoG, in fact FoG is difficult
to elicit during a clinical visit or in the laboratory [13,
17, 18] when participants focus attention on their walking. As walking and turning while dual‐tasking (DT) have
been suggested to induce freezing, the addition of a DT
is often used to elicit FoG in the laboratory environment
[12, 19].
Significant advancements in technology using wearable
inertial sensors provides a new opportunity to objectively
quantify subtle gait disturbances, such as FoG, in both
clinical and laboratory settings [20–22], and ultimately
during daily life [20, 21]. Objective measures of gait disturbances, such as FoG, have the potential to help inform
effects of treatment, disease progression, and characterize fall risk.
Two recent reviews [23, 24] have summarized different approaches to objectively measure FoG with wearable
sensors. However, only three studies were performed in
the home setting and the validity of the algorithms in the
laboratory or home varied considerably (accuracy 79%
to 96%) [25–28]. While studies detecting FoG in a laboratory setting have been well-validated, studies focused
on detecting FoG during daily life are relatively scarse
[23, 25, 26, 29–32]. In addition, the percentage of freezing during daily life, as well as the variability of it, have
not yet been reported. In addition, the impact of FoG
on mobility perception and other gait disturbances have
not yet been investigated during daily life. Finally, opensource solutions to monitor FoG with wearable inertial
sensors in free living conditions are not yet available.
Common algorithms available to many investigators will
improve reproducibility of results, external validation,
algorithm improvements, and ultimately reducing barriers to applying digital health solutions for unsupervised
FoG monitoring.
Here, we aimed to: (1) introduce a novel, objective
algorithm to detect FoG episodes in the laboratory in a
cohort of people with PD with and without freezing of
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gait compared to age-matched controls, and evaluate the
performance of such algorithm with clinicians judgment
of FoG; and (2) extend this approach to characterize FoG
during daily life (7 days recording with inertial sensors
on the feet) as well as investigate the association between
subjects’ perception of freezing severity and other objective measures of walking and turning in a different cohort
of people with PD with, and without, freezing of gait.

Methods
We analyzed the dataset of two studies: Study I took
place in the laboratory to determine validity of detected
freezing events compared to expert rating of videos and
Study II took place in the home setting to compare FoG
episodes and gait between those with, and without, FoG.
Participants
Study I included 45 subjects with PD and 21 healthy controls of similar age while Study II included 48 subjects
with PD. All participants were recruited through the
Parkinson’s Center of Oregon clinic at Oregon Health &
Science University. For both studies, inclusion criteria
were: diagnosis of idiopathic Parkinson’s disease confirmed by a movement disorders neurologist according
to the United Kingdom Parkinson’s disease Society Brain
Bank criteria, Hoehn and Yahr scores of II–IV, and ability
to follow instructions and appreciate research purpose.
For both studies, exclusion criteria were: other factors
affecting gait (hip replacement, musculoskeletal disorder,
uncorrected vision or vestibular problem), or an inability to stand or walk without an assistive device. Study I
included 27 participants classified as freezers, based on
a score of > 0 on the New Freezing of Gait Questionnaire
(NFOGQ) [33] and 18 without FoG. They were all tested
in our laboratory in the “Off ” state, after at least 12-h
overnight withdrawal from anti-parkinsonian medications. We choose to test people with PD Off their medication because FoG is most often observed in Off periods
[34]. Study II included 23 different participants with
PD classified as freezers, based on a score of > 0 on the
NFOG Q as well as 25 participants with PD without FoG.
Both studies were carried out in accordance with the
recommendations of the Oregon Health & Science University (OHSU) institutional review board (IRB) with
written informed consent from all subjects. All subjects
gave written informed consent in accordance with the
Declaration of Helsinki. The protocols were approved by
the OHSU IRB (#9903, #10775 and #15578).
Procedure
Procedure for study I

Participants underwent a 3-h assessment, which included
clinical assessments, questionnaires, and quantitative
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assessments of gait, detailed elsewhere [35]. The gait
assessment analyzed here included two walking conditions, a 2-min walk in a 8-m hallway, and a 1-min walk
with a concurrent cognitive task (reciting alternate letter
of the alphabet). Participants were asked to stand quietly
for few seconds, instructed when to walk 8-m at their
comfortable speed, turn 180°, and keep walking until they
hear stop at the end of 2 (or 1) min test. While performing these walking tasks, participants wore eight wireless,
synchronized inertial sensors (Opals by APDM, Inc.) on
both shins, feet, wrists, on the sternum and on the posterior trunk (over L5). Each inertial sensor includes a
tri-axial accelerometer, gyroscope, and magnetometer
sampling at 128 Hz. Data were wirelessly streamed to
a laptop and stored for offline analysis. All trials were
video-recorded and videos were rated by two movement disorders specialist (DS and JGN), blinded to group
allocation, who assessed each FoG episode, its duration
(short, medium or long) and and total number of FoG
episodes per test. Disease severity was measured with the
Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part III [36]. The MDSUPDRS Part III was administered by a certified examiner.
Procedure for study II

Subjects wore three inertial sensors (same as Study I)
only one on each foot and one over the lumbar area for
a week of continuous monitoring for at least 8 h/day,
details in Shah et al. [37]. The Opal is lightweight (22 g),
has a battery life of 16 h, and includes 8 GB of storage,
which can record over 30 days of data. Subjects removed
the sensors at night and placed them in a charging station. Data were stored in the internal memory of the
Opals. Subjects returned the sensors either by mail, using
a pre-paid box after completion of 1 week of data collection, or a research assistant picked up the sensors at their
homes. Data were uploaded via a laptop to a cloud service
and downloaded to a local computer for analyzing FoG.
Severity of disease was rated based on MDS-UPDRS,
Part III, while participants were on their regular dose of
Levodopa (On state, approximately 1 h after intake). The
MDS-UPDRS Part III was administered by a certified
examiner in a laboratory screening visit. Perceived motor
functioning was assessed using the mobility domain of
the Parkinson’s Disease Questionnaire (PDQ-39) [38].
The PDQ-39 mobility Sect. (10 items) has a possible
score range of 0 to 40; higher scores are associated with
greater impairment.

Data analysis
Video assessment of freezing (study I)

Two independent raters, both with experience in FoG
assessment, analyzed the video-recordings. A FoG
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episode was defined when the gait pattern (alternating right and left steps) was arrested or if it appeared as
if they were trying unsuccessfully to initiate or continue
locomotion/turn. The end of an episode was defined as
the time when an effective step had been performed and
followed by continuous locomotion. At least two effective
steps were required in order to score and time the duration of a freezing episode. The raters were asked to sum,
for each subject, and for each gait condition (walking in
single- and dual-task conditions) the number of FoG episodes using a similar cut‐off duration as in the NFOGQ:
less than 1 s (very short episodes), 2–5 s (short episodes),
and more than 5 s (long episodes).
Freezing detection algorithm, open‑source (study I
and study II)

We present an open-source algorithm to detect numbers
of FoG episodes, percentage of time spent freezing and
its variability during 7 days of unsupervised, daily life
settings (Figs. 1 and 2). We first used the proposed algorithm to compare the number of detected FoG episodes
with the clinical judgment of two movement disorders
experts using Study I, and then apply the proposed algorithm on Study II to characterize FoG during 7 days of
unsupervised monitoring in daily life.
The algorithm first detects the periods of walking, from
the 3D angular velocity and 3D acceleration of the lumbar sensor, in windows of 30 min [39–42]. Briefly, walking bouts of 10 s and longer were then used for further
analysis. Although the algorithm was originally written
for sensors to be placed on the feet, in Study I we also
compared the performance of the algorithm using sensors on the shins.
The FoG algorithm used the antero-posterior accelerations and rotations around the medio-lateral axis of the
gyroscopes of the sensors worn on the feet during each
identified gait bout to identify potential FoG episodes.
It has been shown that freezing is usually accompanied
by high-frequency leg movements [4]. Recently a ‘Freezing Ratio’ was defined as the power in the “freeze band”
(3.5–8 Hz) divided by the power in the “locomotor band”
(0.5–3 Hz) with larger ratios indicating more freezing
[43, 44]. Such ‘high-frequency’ components of gait have
been associated with the ‘trembling’ observed during
freezing episodes. In addition, it has been recently shown
that during regular walking, the correlation between
right and left foot angular velocity is high, while it drops
significantly prior to, and during, a FoG episode [45, 46].
Adopting a similar idea, we used here the information
from both accelerometers and gyroscopes during nonoverlapping windows of 1 s to confirm a FoG episode.
The flowchart of the algorithm is shown in Fig. 2.
First, we use data from the medio-lateral gyroscope to
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Fig. 1 Representative example of signals while walking and freezing

determine the correlation between left and right leg, and
if the correlation value goes below 0.5 than declare that
1-s window as potential FoG episode. Second, we use
antero-posterior accelerometer data to calculate a freezing ratio defined as the ratio of the energy of the signal
during 3–10 Hz (high frequency) to energy of the signal
during 0–3 Hz (low frequency) using FFT. If the freezing ratio is higher than 10, then, that period of time is
declared as a potential FoG episode. Finally, we declare
an actual FoG episode if a specific 1-s window is declared
as potential FoG by both methods (See Fig. 1). Once FoG
episodes are identified, we grouped them into three categories identified in the NFOGQ: very short FoG (< 1 s)
episodes, short FoG (2–5 s) episodes, long FoG (> 5 s)
episodes. Percentage time freezing was calculated as percentage of total time spent freezing over total time spent
walking in 30 min windows. Our primary outcome measure for freezing was the cumulative sum of such percentages across a week of daily recording. In addition, the
variability of the percentage of time spent freezing was
reported.
Initially, we did not merge any individual freezing episodes detected by the algorithm, and the data set (Study
I) was analyzed and compared with data obtained from
clinical raters. While tuning the algorithm, we realized that the algorithm may split long freezing episodes
into multiple, small freezing episodes. This phenomenon could be explained by hesitations or steps during

freezing, which woube be detected by the algorithm (and
identified as non-freezing episodes) but maybe not by
the clinical eye. Therefore, we tried various thresholds to
decide whether to split or not a FoG episode and compared results obtained with the clinicians scores. Results
are in Appendix Table 5 and lead to the choice of merging
freezing episodes with hesitation durations ≤ 2 s as one,
single, freezing episode.
Turning and walking features (study II)

In addition to FoG characterization, we report the following turning and walking features during daily life monitoring (Study II), using methodology published elsewhere
[37, 47], not part of the open-source algorithm.
Turning features the algorithm used the horizontal
rotational rate (yaw) of the lumbar sensor during each
identified gait bout. Details are described elsewhere [39].
Briefly, a turn was defined as a trunk rotation around
the vertical plane with a minimum of 15 °/s [39]. Turning angle was then obtained integrating the angular rate
of the lumbar sensor around the vertical axis (done separately for each turn). The following turning characteristics were averaged across the week for number of turns
per each 30-min period: number of turns, average turning angle (°), average turning duration (s), average turn
peak velocity (°/s) and the coefficient of variation (CV)
was calculated for the turn peak velocity.
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Fig. 2 Schematic of the algorithm for FoG detection

Walking features A separate algorithm, using
Unscented Kalman Filter to fuse information from the
accelerometers, gyroscopes, and magnetometers to estimate the orientation and position trajectory of the sensors on the feet, was used to quantify quality of walking
[37, 47]. Gait was defined as walking bouts of at least 3
consecutive strides, a minimum duration of 3 s and intermittent breaks of no longer than 6 s. The selected outcomes for walking were gait speed (m/s), and the pitch
angle of the foot at initial contact (°) selected as an indicator of shuffling as well as the variability of the pitch angle
of the foot at initial contact. All outcomes were averaged
across the hours of recording. Steps that occurred during
turning were excluded.
Statistical analysis

In both studies, Independent sample t-tests compared
age, disease duration, and MDS-UPDRS Part III between
people with and without FoG.

Study I To evaluate the agreement between the two
clinical raters, and between the algorithm and the raters,
we used an Intra-Class Correlation Coefficient (ICC)
[48]. In accordance with previous studies [11, 49], we
used the following classification of ICC power: < 0.2 negligible, 0.2 ≤ 0.4 weak, 0.4 ≤ 0.7 moderate, 0.7 ≤ 0.9 strong,
and > 0.9 very strong. In addition, the mean and 95% ICC
confidence interval as well as the number of FOG events
were reported. To investigate the performance of the
algorithm against the classification of freezer vs. nonfreezer based on clinical raters, we computed the Area
Under Curve (AUC), and various performance metrics
(such as accuracy, sensitivity, specificity).
Study II To investigate whether quantity and quality
of mobility outcomes differed between the two groups,
linear mixed models were fit for each outcome, with
and without adding disease duration as a covariate to
account for variations in the presented outcomes with
disease duration. Lastly, Pearson’s correlation was used
to evaluate the association between objective measures of
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freezing and the clinical or extracted measures of quantity and quality of mobility at home. The statistical analysis was performed in MATLAB R2018b (The Mathworks
Inc., Natick, MA, USA) using the Statistics and Machine
Learning Toolbox. A significance level of 0.05 was used
throughout.

Results
Briefly, people with and without FoG were similar in
both studies for age, and MDS-UPDRS III, while people
with FoG presented higher disease duration compared to
people without FoG (p < 0.05), only for the participants
of Study II. Demographics and clinical characteristics of
participants with PD for Study I and II are summarized
in Table 1.
Study I: comparison between objective and clinically
detected FoG

between the objective FoG calculated from the sensors
on feet and the average clinical raters compared to the
ICCs between the objective measures of FoG calculated
from the sensors on the shins and the average clinical
raters. In addition, the ICCs for the very short FoG episodes were poor for sensors on the feet or shins.
Moreover, healthy controls and PD-FoG showed a significantly lower % time spent freezing during walking
compared to PD + FoG, see boxplot in Fig. 3.
The algorithm performance to classify non-freezers
vs. freezers against the clinical raters are summarized in
Table 3. Specifically, the AUC value to discriminate nonfreezers from freezers using the algorithm versus clinical
rater 1 was 0.93, and versus clinical rater 2 was 0.89. The
performance of the algorithm were slightly higher when
compared to clinical rater 1 compared to clinical rater 2.
Study II: FOG in daily life

A total of 79 FoG events were identified from clinician
rater I and a total of 150 FoG episodes were identified
from clinician rater II. The discrepancy between the two
raters was mainly due to the detection of the very short
FoG episodes (< 1 s) with an ICC of 0.39, while the agreement is overall strong for short (2 to 5 s) and long episodes (> 5 s) with ICC of respectively 0.839 and 0.875.
In general, ICCs during dual-task walking showed a
tendency to be lower compared to ICCs calculated for
single-task walking for very short and short FoG episodes. Table 2 shows the number of identified episodes
and ICCs for single- and dual-task walking separately as
well as overall between raters and between raters (averaged) and the algorithm with sensors in two different
placements (feet and shins). The overall ICCs were higher

Based on the ICC results of Study I, we deemed it unreliable to record very short FoG episodes during daily life.
Therefore, Study II used the percent of time spent FoG
as a sum of short (2 to 5 s) and long (> 5 s) FoG episodes.
The extracted FoG proxy, percent of time spent FoG
(average of 30-min windows) was higher (p = 0.04) while
the variability of time spent FoG was lower (p = 0.02) in
people who identified themselves as freezers, according
to the NFOG, compared to people who identified themselves as non-freezers, see details in Table 4. After adding
disease duration as a covariate, such differences between
freezers and nonfreezers did not change (p < 0.01).
In PD + FoG, we found on average 18 FoG episodes
(average of 30-min windows) where 69% of the episodes
consisted of short FoG episodes (2-5 s). The remainer

Table 1 Demographics and clinical characteristics for participants in Study I and Study II
Study I

Non-freezers
(N = 18)
Mean

Freezers
(N = 27)
SD

Mean

p-value
SD

Age (years)

70.3

7.0

69.6

7.4

0.723

Disease duration (years)

8.2

4.7

9.0

6.3

0.862a

11.6

46.7

12.2

UPDRS III ON

43.6

Gender (F/M)

4/14

6/21

1

Study II

Non-freezers
(N = 25)

Freezers
(N = 23)

p-value

Mean

SD

Mean

0.402

SD

Age (years)

67.8

4.8

69.6

7.1

0.320

Disease Duration (years)

6.6

3.7

13.0

6.5

0.0002

UPDRS III ON

33.7

9.9

34.1

12.7

Gender (F/M)

14/11

a

Mann-Whitney U-test

6/17

0.913
0.071
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Table 2 ICC between the two clinical raters, as well as ICC between the average of the clinical raters and the algorithm
based on IMUs on the feet and the algorithm based on IMUs on the shins
Video

# of detected
episodes

ICC (2,1)- CI

# of detected
episodes

ICC (2,1)- CI

Rater 1 vs Rater 2

Rater 1

Rater 2

Very Short
episodes (< 1 s)

Rater 1

Rater 2

Short episodes (2 Rater 1
to 5 s)

Rater 2

Long episodes
(> 5 s)

Walk 2-min ST

7

45

0.396 (− 0.210 to
0.698)

35

31

0.892 (0.795 to
0.943)

13

9

0.848 (0.707 to
0.921)

Walk 1-min DT

3

25

0.346 (− 0.375 to
0.689)

13

30

0.743 (0.492 to
0.870)

8

10

0.929 (0.857 to
0.964)

Overall

10

70

0.390 (− 0.005 to
0.629)

48

61

0.839 (0.746 to
0.899)

21

19

0.875 (0.801 to
0.922)

Wearable sensors # of detected
on feet
episodes

ICC (2,1)- CI

# of detected
episodes

ICC (2,1)- CI

# of detected
episodes

Algorithm vs
Raters

Algorithm

Raters

Very Short
episodes (< 1 s)

Algorithm

Raters

Short episodes (2 Algorithm
to 5 s)

Raters

Long episodes
(> 5 s)

Walk 2-min ST

71

26

0.474 (0.025 to
0.718)

36

33

0.915 (0.841 to
0.955)

7

11

0.872 (0.761 to
0.932)

Walk 1-min DT

57

14

0.355 (− 0.161 to
0.658)

12

22

0.387 (− 0.171 to
0.683)

6

9

0.932 (0.865 to
0.966)

Overall

128

40

0.431 (0.018 to
0.662)

48

55

0.818 (0.714 to
0.884)

13

20

0.895 (0.833 to
0.934)

Wearable sensors # of detected
on shins
episodes

ICC (2,1)- CI

# of detected
episodes

ICC (2,1)- CI

# of detected
episodes

Algorithm vs
Raters

Algorithm

Raters

Very Short
episodes (< 1 s)

Algorithm

Raters

Short episodes (2 Algorithm
to 5 s)

Raters

Long episodes
(> 5 s)

Walk 2-min ST

94

26

0.374 (− 0.175 to
0.666)

24

33

0.703 (0.443 to
0.842)

4

11

0.688 (0.414 to
0.833)

Walk 1-min DT

49

14

− 0.176 (− 1.306 to 20
0.400)

22

0.619 (0.252 to
0.806)

4

9

0.814 (0.636 to
0.905)

Overall

143

40

0.304 (− 0.095 to
0.558)

55

0.672 (0.485 to
0.792)

8

20

0.744 (0.597 to
0.837)

44

were long episodes (> 5), and only 1% of the episodes
were over 30 s, see Fig. 4.
Quantity of mobility, such as average number of turns,
average number of bouts and average bout durations,
were similar in people with and without FoG (Table 4).
However, measures of quality of mobility, such as average pitch angle of the feet while walking, average turn
angle, and average turn duration were significantly
smaller in people with FoG compared to people without
FoG (p < 0.05, see Table 4). In addition, variability of pitch
angle of the feet during walking was significantly larger
in people with FoG, compared to people without FoG
(p < 0.05, see Table 4). Other measures of quality of walking and turning, such as gait speed, and average, turning, peak velocity were similar between people with and
without FoG (p > 0.05, see Table 4). However, when considering disease duration as a covariate, only average turn
angle was still significantly smaller (p < 0.0001) in people
with FoG, compared to people without FoG.

# of detected
episodes

ICC (2,1)- CI

ICC (2,1)- CI

ICC (2,1)- CI

The average% of time spent freezing (in people who
self-identified as freezers) was significantly associated
with the MDS-UPDRS III, but not to objective measures
of walking and turning at home. The CV of the time spent
FoG was associated with both MDS-UPDRS Part III and
to the mobility sub-score of the PDQ-39, see radar plot
in Fig. 5.

Discussion
This study introduces a novel, automated algorithm for
detection and objective characterization of FoG episodes
from inertial sensors on the feet. The proposed algorithm is simple and threshold-based, with one threshold
based on angular velocity data and one on accelerometry
data, to identify FoG episodes. Overall, we showed better agreement between clinical raters and the algorithm
in detecting the number of FoG episodes in the laboratory (Study I) for long FoG episodes. In fact, for veryshort and short FoG episodes, the ICCs during dual-task
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Fig. 3 Box plot of the percent of time spent freezing during walking
in the laboratory in healthy controls, PD − FoG and PD + FoG

walking were lower compared to ICCs calculated for single-task walking.
Further, we explored this approach during unsupervised home monitoring (Study II) and found that the
proposed FoG proxies, percent of walking time spent
freezing and the variability of time spent freezing, were
different between people with and without FoG. The percent of walking time spent freezing also was related to
disease severity, measured with the MDS-UPDRS Part III
and perception of mobility, measured with the mobility
sub-score of the PDQ-39.
Here, we modified a threshold-based approach to
detect FoG recently presented [50]. Specifically, the proposed open-source algorithm first detects periods of
walking and turning [42, 50], then applies two thresholds, which need to be satisfied to label an episode as a
“FoG episode”. Specifically, the first threshold is on the
spectral power of the data coming from the accelerometers, a common way to identify FoG presence, based
on the high-frequency components of the legs trembling [51]. This method has well-known advantages and

Table 3 Performance of the algorithm with clinical raters in classifying Non-freezers vs Freezers
Non-freezers vs freezers

AUC

Best Threshold

Accuracy

Sensitivity

Specificity

False positive
rate

False
negative
rate

Rater 1 vs algorithm

0.93

0.09

0.88

0.89

0.88

0.13

0.11

Rater 2 vs algorithm

0.89

0.13

0.85

0.80

0.87

0.13

0.20

Table 4 Means and SD of the quantity and quality of mobility measures over 7 days of continuous monitoring
Quantity of mobility

Non-freezers
Mean

Freezers
SD

Mean

p-value

p-value (adjusted)

SD

Total recording (hours)

49.7

9.3

52.0

19.4

0.600

0.855

Average turns #

38.3

15.3

45.2

28.2

0.300

0.827

Average bouts #

6.2

1.0

6.3

1.4

0.680

0.312

Total bouts time (hours)

3

1.5

4.2

3.1

0.08

0.22

Time spent freezing (%)

15.42

4.69

20.18

10.15

0.040

0.006

CV time spent freezing (−)

0.848

0.224

0.024

0.007

Average gait speed (m/s)

0.87

0.13

Average pitch angle (°)

− 17.0

5.1

Freezing proxy
0.703

0.206

0.87

Quality of mobility

  CV Pitch Angle (−)
Average turn angle (°)
Average turn duration (s)
Average turn peak velocity (°/s)
CV turn peak velocity (−)

0.24

0.960

0.802

− 13.1

6.0

0.020

0.108

0.415

0.010

0.154

87.2

4.9

< 0.0001

< 0.0001

− 0.487

0.238

− 0.746

94.3

4.6

2.1

0.2

1.9

0.3

0.001

0.056

77.0

9.4

80.5

12.4

0.270

0.924

0.311

0.031

0.940

0.744

0.311

0.032

p-values from linear mixed models are reported, considering (p-value adjusted) or not (p-value) disease duration as covariate, p-values < 0.05 are in bold
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Fig. 4 Pie chart summarizing the composition of the average FoG
episodes duration

Fig. 5 Radar plot summarizing the correlation between % of time
spent FoG and its variability with clinical and objective measures
of quality and quantity of walking and turning over 7 days of
continuous monitoring at home

disadvantages [24, 52], and can improve the detection of
FoG episodes. To also detect FoG episodes not involving
trembling of the knees, we added a threshold, based on
the correlation between the right and left angular velocity of the feet. Usually, during regular walking, the correlation between right and left foot angular velocity is
high, while it drops significantly prior to, and during, a
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FoG episode [45, 46]. The same approach can be applied
to wearable sensors placed on the feet or shins. In the
present study, while evaluating the performance of this
approach with the clinical raters, we found that: (1) the
overall agreement between clinical and objective detection of FoG is strong when the sensors are placed on the
feet, and moderate when the sensors are placed on the
shins, (2) both the agreement between the two clinical
raters, as well as the agreement between clinical raters
and objective measures are better for the short (2–5 s)
and long (> 5 s) FoG duration, whereas both agreements
are poor for the very short FoG episodes (< 1 s); (3) in
general the agreement in the dual-task walking condition
seem lower compared to the single-task walking conditions for the short FoG episodes.
Recently, machine learning based methods [24] (neural networks, decision trees, random forest, and support
vector machine) have been proposed to surpass the FoG
detection abilities of threshold-based methods. However,
it is still unclear whether an algorithm that matches perfectly with clinical judgement is needed, even more so,
when there is still discrepancy among clinical raters with
more or less experience in detecting the same FoG episodes specifically for very short FoG episodes where the
agreement between different raters is poor. Moreover,
despite the higher sensitivity in detecting the occurrence
of even shorter FOG episodes compared to the previous method [24] (an accuracy above 90% was achieved),
these approaches may require a higher computational
cost, requiring up to several seconds from the occurrence of the episode to its detection, making those algorithms not suitable for real-time interventions, such as
cueing. However, nowadays, the use of floating-point
unit microcontrollers could overcome this limitation,
in fact, such microcontrollers could compute advanced
machine learning algorithms in real time with low power
consumption.
Overall, the proposed approach reached AUC of 0.89
to 0.93 in discriminating people experiencing FoG or not,
when FoG was classified by movement disorder neurologists. These AUCs and relative sensitivity, specificity and
accuracy are similar to what reported in the literature
using a variety of approaches [23, 24]. Lastly, we observed
lower agreement between raters and the algorithm for
short episodes during dual-task walking. Although this
should be verified in a separate cohort, a pontential explanation could be related to decrease smoothness of walking in people with PD and particularly in freezers [53,
54]. It could be possible that dual-task further decreases
smoothness of gait, such decrease may be picked up as
freezing by the algorithm but not by the clinical raters.
After comparing the algorithm with clinical judgment in the laboratory, we extended our approach to
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unsupervised monitoring during daily life for 7 days in
48 people with PD, 23 of which reported having FoG
according to the NFOGQ. The percentage of time spent
freezing was significantly higher in those people who
report themselves as freezers compared to non-freezers,
while the variability of time spent freezing was lower in
those reporting FoG. The lower variability found in freezers may indicate that a certain amount of FoG is present
across the day and week. Instead, the higher variability
found in the non-freezers may either indicate that we are
picking up subtle hesitations that are not constantly present over the day, therefore increasing the variability, or
the high variability could be due to a high false positive
rate. Therefore, to confirm this finding, we would need
to first validate the algorithm during daily life and follow
longitudinally the same cohort of people with PD who
does not report FoG at baseline.
Interestingly, we found that the short, 2–5 s duration,
FoG episodes account for 69% of all episodes, while the
rest are long (5–30 s) episodes, 1% of which have duration over 30 s. This suggests that short FoG episodes are
the most common during the day. The percent of walking time spent freezing and its variability were related to
disease severity, measured with the MDS-UPDRS Part
III and to perceived mobility, measured with the PDQ39, only in the freezers. The association between percent
time spent freezing and the MDS-UPDRS Part III is not
totally surprising, as freezing severity tends to increase
with disease severity. The association between the variability of time spent freezing and mobility perception
suggests that FoG may affect the perception of mobility
in people with PD. Our objective measures of FoG during
7 days of continuous monitoring were not significantly
associated with the NFOGQ performed at the beginning
of the study, indicating that perception of FoG may be
differ from the measured FoG over a week of monitoring. Although surprising, this may, in part, be explained
by the items composing the NFOGQ. The questionnaire
asks about the impact of freezing in daily life, in addition
to the presence and severity of freezing. For some people,
even mild freezing may significantly disturb walking,and
cause fear of falling that may significantly impact or cause
people to avoid activities of daily life.
We also characterize quantity and quality of walking
and turning over 7 days of continuous monitoring. Our
findings are in keeping with studies showing that quantity of walking and turning is similar among people with
and without FoG [42, 55] while quality of walking and
turning may be more affected in people with FoG. Specifically, the average pitch angle at initial contact of foot
with the ground was significantly smaller in freezers
compared to non-freezers, consistent with more shuffling gait and more falls in freezers than non-freezers.
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The large variability of the pitch angle at initial contact
and the high variability of the time spent freezing could
potentially reflect fluctuations in number of freezing episodes due to periodic medication intake throughout the
day.
In addition, the average turning angle was smaller
in freezers compared to non-freezers, as previously
reported in a larger cohort [42]; and such difference could
potentially be attributed to the fact that freezers may
avoid larger turning angles, known to elicit more freezing, and explain that turning duration was significantly
shorter in freezers. However, after correcting these outcomes for disease duration, only turning angle was still
statistically significant, suggesting that gait disturbances
such as shuffling are related to disease duration more
than to freezing of gait. Turning angle was still significantly smaller in freezers compared to non-freezers after
correcting for disease duration suggesting that freezers
may modify their turning in order to avoid FoG. However, it is also possible that average turning angles were
measured as small in freezers because they hesitated during a turn such that a large turn was detected as several
small turns.
These findings, although promising, should be taken
cautiously. Future work will need to validate the algorithm on a new dataset, increase the number of subjects at home and determine the validity of our objective
freezing measures in daily life. Specifically, we plan to
use either a mini-camera pointed at the feet or pressure
insoles as a gold standard comparison for home recording of gait and turning, for comparison with the inertial
sensor data. It is also possible that some participants with
FoG show akinetic freezing, not involving trembling of
the knees, so these events may not be identified with our
threshold approach. At this time, we hope that by making this algorithm available to researchers, we could,
together, further improve FoG detection.

Conclusions
Overall, here we presented an objective measure of
freezing with wearable technology to be used in the
laboratory. Its validity would need to be determined for
continuous monitoring in unsupervised settings. These
metrics could have tremendous value to assess the efficacy of interventions such as medications and rehabilitation on the quality of mobility and frequency of FoG
during community-living.
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Table 5 ICCs changes based on merging or not subsequent FoG episodes. Window of merging goes from no merging
at all (No gap) to 5s gap in merging subsequent episodes. The ICC is between the average of the clinical raters
and the algorithm based on IMUs on the feet and the algorithm based on IMUs on the shins.
No gap
2 minute ST
1 minute DT
Overall

1 sec gap
2 minute ST
1 minute DT
Overall

2 sec gap
2 minute ST
1 minute DT
Overall

3 sec gap
2 minute ST
1 minute DT
Overall

4 sec gap
2 minute ST
1 minute DT
Overall

5 sec gap
2 minute ST
1 minute DT
Overall

Wearables on feet vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.651 (.346 to .814)
.914 (.839 to .954)
.618 (.283 to .796)
.469 (-.041 to .729)
.846 (.698 to .921)
.618 (.252 to .805)
.593 (.359 to .741)
.894 (.833 to .932)
.618 (.399 to .757)

No gap

Wearables on feet vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.511 (.006 to .753)
.931 (.871 to .963)
.828 (.675 to .909)
.312 (-.184 to .626
.734 (.485 to .864)
.923 (.836 to .962)
.432 (-0.43 to .678)
.883 (.816 to .925)
.866 (.777 to .917)

1 sec gap

Wearables on feet vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.474 (.025 to .718)
.915 (.841 to .955)
.872 (.761 to .932)
.355 (-.161 to .658)
.387 (-.171 to .683)
.932 (.865 to .966)
.431 (.018 to .662)
.818 (.714 to .884)
.895 (.833 to .934)

2 sec gap

2 minute ST
1 minute DT
Overall

2 minute ST
1 minute DT
Overall

2 minute ST
1 minute DT
Overall

Wearables on feet vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.007 (-.582 to .415)
-0.86 (-1.073 to .426)
.519 (0.91 to .745)
-.343 (-1.227 to .248)
-.219 (-1.239 to .356)
.000 (-.764 to .459)
-.105 (-.542 to .236)
-0.81 (-.711 to .315)
.410 (.073 to .624)

3 sec gap

Wearables on feet vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.474 (.025 to .718)
.915 (.841 to .955)
.872 (.761 to .932)
.335 (-.157 to .638)
.214 (-.481 to .590)
.706 (.423 to .850)
.445 (.066 to .663)
.799 (.684 to .872)
.818 (.714 to .884)

4 sec gap

Wearables on feet vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.469 (.023 to .714)
.904 (.820 to .949)
.857 (.733 to .923)
.339 (-.156 to .641)
.180 (-.527 to .571)
.640 (.287 to .817)
.445 (.084 to .659)
.787 (.666 to .864)
.786 (.663 to .864)

2 minute ST
1 minute DT
Overall

2 minute ST
1 minute DT
Overall

5 sec gap
2 minute ST
1 minute DT
Overall

Wearables on shins vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.438 (-.054 to .700)
.679 (.398 to .829)
.000 (-.875 to .467)
.294 (-.384 to .640)
.880 (.764 to .939)
.000 (-.961 to .490)
.416 (.081 to .629)
.780 (.655 to .860)
.000 (-.573 to .364)
Wearables on shins vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.404 (-.118 to .682)
.663 (.369 to .821)
.257 (-.394 to .604)
.468 (-.043 to .729)
.173 (-.622 to .578)
.833 (.672 to .915)
.374 (.016 to .602)
.740 (.591 to .835)
.345 (-.031 to .583)
Wearables on shins vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.374 (-.175 to .666)
.703 (.443 to .842)
.688 (.414 to .833)
-.176 (-1.306 to .400)
.619 (.252 to .806)
.814 (.636 to .905)
.304 (-.095 to .558)
.672 (.485 to .792)
.744 (.597 to .837)
Wearables on shins vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.617 (.282 to .796)
.660 (.362 to .818)
.381 (-.161 to .670)
-.268 (-1.486 to .354)
.399 (-.178 to .694)
.680 (.372 to .837)
.300 (-.102 to .555)
.548 (.289 to .713)
.667 (.477 to .788)
Wearables on shins vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.416 (-.095 to .689)
.616 (.280 to .795)
.716 (.468 to .849)
-.380 (-1.707 to .296)
.182 (-.603 to .583)
.120 (-.725 to .551)
.304 (-.095 to .558)
.493 (.203 to .678)
.573 (.328 to .728)
Wearables on shins vs raters ICC (2,1)- CI
Very Short episodes (<1s) Short episodes (2 to 5s)
Long episodes (> 5s)
.437 (-0.56 to .700)
.616 (.280 to .795)
.691 (.420 to .835)
-.401 (-1.748 to .286)
-.018 (-.996 to .481)
.059 (-.846 to .520)
.322 (-.066 to .569)
.451 (.137 to .651)
.549 (.290 to .713)

Mancini et al. J NeuroEngineering Rehabil

(2021) 18:1

Received: 22 April 2020 Accepted: 12 October 2020

References
1. Morris ME, Huxham FE, McGinley J, Iansek R. Gait disorders and gait
rehabilitation in Parkinson’s disease. Adv Neurol. 2001;87:347–61.
2. Morris ME, Iansek R, Galna B. Gait festination and freezing in Parkinson’s
disease: pathogenesis and rehabilitation. Mov Disord. 2008;23(Suppl
2):S451–60.
3. Giladi N, Nieuwboer A. Understanding and treating freezing of gait in
parkinsonism, proposed working definition, and setting the stage. Mov
Disord. 2008;23(Suppl 2):S423–5.
4. Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A. Freezing
of gait: moving forward on a mysterious clinical phenomenon. Lancet
Neurol. 2011;10(8):734–44.
5. Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson’s disease beyond its relationships with mobility and
gait. Mov Disord. 2007;22(15):2192–5.
6. Okuma Y. Practical approach to freezing of gait in Parkinson’s disease.
Pract Neurol. 2014;14(4):222–30.
7. Nonnekes J, Snijders AH, Nutt JG, Deuschl G, Giladi N, Bloem BR.
Freezing of gait: a practical approach to management. Lancet Neurol.
2015;14(7):768–78.
8. Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J.
Clinical and methodological challenges for assessing freezing of gait:
future perspectives. Mov Disord. 2019;34(6):783–90.
9. Morris TR, Cho C, Dilda V, Shine JM, Naismith SL, Lewis SJ, et al. A comparison of clinical and objective measures of freezing of gait in Parkinson’s
disease. Parkinsonism Relat Disord. 2012;18(5):572–7.
10. Gilat M. How to annotate freezing of gait from video: a standardized
method using open-source software. J Parkinson’s Dis. 2019;9(4):821–4.
11. Morris TR, Cho C, Dilda V, Shine JM, Naismith SL, Lewis SJ, et al. Clinical
assessment of freezing of gait in Parkinson’s disease from computergenerated animation. Gait Posture. 2013;38:326.
12. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. The factors that induce
or overcome freezing of gait in parkinson’s disease. Behav Neurol.
2008;19:456298.
13. Snijders AH, Nijkrake MJ, Bakker M, Munneke M, Wind C, Bloem BR. Clinimetrics of freezing of gait. Mov Disord. 2008;23(Suppl 2):S468–74.
14. Spildooren J, Vercruysse S, Desloovere K, Vandenberghe W, Kerckhofs E,
Nieuwboer A. Freezing of gait in Parkinson’s disease: the impact of dualtasking and turning. Mov Disord. 2010;25(15):2563–70.
15. Plotnik M, Giladi N, Hausdorff JM. Bilateral coordination of gait and Parkinson’s disease: the effects of dual tasking. J Neurol Neurosurg Psychiatry.
2009;80(3):347–50.
16. Robles-García V, Corral-Bergantiños Y, Espinosa N, Jácome MA, GarcíaSancho C, Cudeiro J, et al. spatiotemporal gait patterns during overt
and covert evaluation in patients with Parkinson´s disease and healthy
subjects: is there a hawthorne effect? J Appl Biomech. 2015;31(3):189–94.
17. Heremans E, Nieuwboer A, Vercruysse S. Freezing of gait in Parkinson’s
disease: where are we now? Curr Neurol Neurosci Rep. 2013;13(6):350.
18. Snijders AH, Haaxma CA, Hagen YJ, Munneke M, Bloem BR. Freezer or
non-freezer: clinical assessment of freezing of gait. Parkinsonism Relat
Disord. 2012;18(2):149–54.
19. Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of
freezing of gait in Parkinson’s disease. J Neurol Sci. 2006;248(1–2):173–6.
20. Del Din S, Godfrey A, Mazza C, Lord S, Rochester L. Free-living monitoring of Parkinson’s disease: Lessons from the field. Mov Disord.
2016;31(9):1293–313.
21. Patel S, Park H, Bonato P, Chan L, Rodgers M. A review of wearable sensors and systems with application in rehabilitation. J Neuroeng Rehabil.
2012;9(1):21.
22. Thorp JE, Adamczyk PG, Ploeg HL, Pickett KA. Monitoring motor
symptoms during activities of daily living in individuals with Parkinson’s
disease. Front Neurol. 2018;9:1036.
23. Silva de Lima AL, Evers LJW, Hahn T, Bataille L, Hamilton JL, Little MA, et al.
Freezing of gait and fall detection in Parkinson’s disease using wearable
sensors: a systematic review. J Neurol. 2017;264(8):1642–54.

Page 12 of 13

24. Pardoel S, Kofman J, Nantel J, Lemaire ED. Wearable-sensor-based detection and prediction of freezing of gait in Parkinson’s disease: a review.
Sensors. 2019;19(23):5141.
25. Sigcha L, Costa N, Pavón I, Costa S, Arezes P, López JM, et al. Deep learning
approaches for detecting freezing of gait in Parkinson’s disease patients
through on-body acceleration sensors. Sensors. 2020;20(7):1895.
26. Rodríguez-Martín D, Samà A, Pérez-López C, Català A, Moreno Arostegui
JM, Cabestany J, et al. Home detection of freezing of gait using support
vector machines through a single waist-worn triaxial accelerometer. PLoS
ONE. 2017;12(2):e0171764.
27. Rodríguez-Martín D, Samà Monsonís A, Pérez C, Català A, Mestre B,
Alcaine S, et al. Comparison of Features, Window Sizes and Classifiers in
Detecting Freezing of Gait in Patients with Parkinson’s Disease Through a
Waist-Worn Accelerometer. 2016.
28. Tzallas AT, Tsipouras MG, Rigas G, Tsalikakis DG, Karvounis EC, Chondrogiorgi M, et al. PERFORM: a system for monitoring, assessment and management of patients with Parkinson’s disease. Sensors (Basel, Switzerland).
2014;14(11):21329–57.
29. Camps J, Samà A, Martín M, Rodríguez-Martín D, Pérez-López C, Alcaine S,
et al editors. Deep learning for detecting freezing of gait episodes in Parkinson’s disease based on accelerometers. Cham: Springer International
Publishing; 2017.
30. Mazilu S, Calatroni A, Gazit E, Roggen D, Hausdorff JM, Tröster G, editors.
Feature learning for detection and prediction of freezing of gait in Parkinson’s disease. Berlin: Springer; 2013.
31. Mazilu S, Hardegger M, Zhu Z, Roggen D, Tröster G, Plotnik M, et al. editors. Online detection of freezing of gait with smartphones and machine
learning techniques. 2012 6th International Conference on Pervasive
Computing Technologies for Healthcare (PervasiveHealth) and Workshops; 2012 21–24 May 2012.
32. Samà A, Rodríguez-Martín D, Pérez-López C, Català A, Alcaine S, Mestre
B, et al. Determining the optimal features in freezing of gait detection
through a single waist accelerometer in home environments. Pattern
Recog Lett. 2018;105:135–43.
33. Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes
T, et al. Reliability of the new freezing of gait questionnaire: agreement
between patients with Parkinson’s disease and their carers. Gait Posture.
2009;30(4):459–63.
34. Giladi N. Medical treatment of freezing of gait. Mov Disord. 2008;23(Suppl
2):S482–8.
35. Mancini M, Smulders K, Harker G, Stuart S, Nutt JG. Assessment of the
ability of open- and closed-loop cueing to improve turning and freezing
in people with Parkinson’s disease. Sci Rep. 2018;8(1):12773.
36. Goetz CG. Movement disorder society-unified Parkinson’s disease rating
scale (MDS-UPDRS): a new scale for the evaluation of Parkinson’s disease.
Rev Neurol (Paris). 2010;166(1):1–4.
37. Shah VV, McNames J, Mancini M, Carlson-Kuhta P, Spain RI, Nutt JG, et al.
Quantity and quality of gait and turning in people with multiple sclerosis,
Parkinson’s disease and matched controls during daily living. J Neurol.
2020;267(4):1188–96.
38. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s
Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–7.
39. El-Gohary M, Pearson S, McNames J, Mancini M, Horak F, Mellone S, et al.
Continuous monitoring of turning in patients with movement disability.
Sensors. 2013;14(1):356–69.
40. Mancini M, El-Gohary M, Pearson S, McNames J, Schlueter H, Nutt JG,
et al. Continuous monitoring of turning in Parkinson’s disease: rehabilitation potential. Neurorehabilitation. 2015;37(1):3–10.
41. Mancini M, Schlueter H, El-Gohary M, Mattek N, Duncan C, Kaye J, et al.
Continuous monitoring of turning mobility and its association to falls and
cognitive function: a pilot study. J Gerontol Ser A. 2016;71(8):1102–8.
42. Mancini M, Weiss A, Herman T, Hausdorff JM. Turn around freezing:
community-living turning behavior in people with Parkinson’s disease.
Front Neurol. 2018;9:18.
43. Moore ST, Yungher DA, Morris TR, Dilda V, MacDougall HG, Shine JM, et al.
Autonomous identification of freezing of gait in Parkinson’s disease from
lower-body segmental accelerometry. J Neuroeng Rehabil. 2013;10:19.
44. Mancini M, Smulders K, Cohen RG, Horak FB, Giladi N, Nutt JG. The clinical
significance of freezing while turning in Parkinson’s disease. Neuroscience. 2017;343:222–8.

Mancini et al. J NeuroEngineering Rehabil

(2021) 18:1

45. Palmerini L, Rocchi L, Mazilu S, Gazit E, Hausdorff JM, Chiari L. Identification of characteristic motor patterns preceding freezing of gait in
Parkinson’s disease using wearable sensors. Front Neurol. 2017;8:394.
46. Dale ML, Mancini M, Curtze C, Horak FB, Fling BW. Freezing of gait associated with a corpus callosum lesion. J Clin Mov Disord. 2016;3:2.
47. Shah V, McNames J, Mancini M, Carlson-Kuhta P, El-Gohary M, Nutt J, et al.
Digital biomarkers of mobility in Parkinson’s disease during daily living. J
Parkinson’s Dis. 2020;10(3):1099–111.
48. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–8.
49. Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N.
Characterization of freezing of gait subtypes and the response of each to
levodopa in Parkinson’s disease. Eur J Neurol. 2003;10(4):391–8.
50. Mancini M, Curtze C, Stuart S, El-Gohary M, James, McNames, et al.
The Impact Of Freezing Of Gait On Balance Perception And Mobility In
Community-Living With Parkinson’S Disease. Conference proceedings :
Annual International Conference of the IEEE Engineering in Medicine and
Biology Society IEEE Engineering in Medicine and Biology Society Annual
Conference. 2018;2018:3040–3043.
51. Moore ST, MacDougall HG, Ondo WG. Ambulatory monitoring of freezing
of gait in Parkinson’s disease. J Neurosci Methods. 2008;167(2):340–8.

Page 13 of 13

52. Bachlin M, Plotnik M, Roggen D, Maidan I, Hausdorff JM, Giladi N, et al.
Wearable assistant for Parkinson’s disease patients with the freezing of
gait symptom. IEEE Trans Inf Technol Biomed. 2010;14(2):436–46.
53. Beck Y, Herman T, Brozgol M, Giladi N, Mirelman A, Hausdorff JM. SPARC:
a new approach to quantifying gait smoothness in patients with Parkinson’s disease. J Neuroeng Rehabil. 2018;15(1):49.
54. Pinto C, Schuch CP, Balbinot G, Salazar AP, Hennig EM, Kleiner AFR, et al.
Movement smoothness during a functional mobility task in subjects
with Parkinson’s disease and freezing of gait – an analysis using inertial
measurement units. J Neuroeng Rehabil. 2019;16(1):110.
55. Weiss A, Herman T, Giladi N, Hausdorff JM. New evidence for gait
abnormalities among Parkinson’s disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days. J Neural
Transmission. 2015;122(3):403–10.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Ready to submit your research ? Choose BMC and benefit from:

• fast, convenient online submission
• thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
• gold Open Access which fosters wider collaboration and increased citations
• maximum visibility for your research: over 100M website views per year
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions

